永利皇冠登录

永利皇冠登录

永利皇冠登录

永利皇冠登录


This data might not be the latest available

Upcoming events皇冠官网

J.P. Morgan European Healthcare Conference [Management] 永利皇冠登录

H1 2020 Results永利皇冠登录


皇冠官网

 


皇冠官网

永利皇冠登录

皇冠登录wellcome

Thomas Kudsk Larsen

皇冠官网手机地址

Henry Wheeler

Oncology

皇冠登录网址2

Josie Afolabi

BioPharmaceuticals (Respiratory & Immunology)

皇冠官网注册

Craig Marks

Finance, fixed income

皇冠官网手机地址

Christer Gruvris

BioPharmaceuticals (CV, Metabolism)

皇冠登录地址

Tom Waldron

Other medicines

皇冠登录网址

Jennifer Kretzmann

Corporate access, retail investors

皇冠官网

Nick Stone

BioPharmaceuticals (Renal), ESG

US general enquiries


  • 永利皇冠登录

    Please find relevant shareholder information and shareholder tools on this page


  • 永利皇冠登录

    Answers to frequently asked shareholder questions


  • 永利皇冠登录

    We apply the principles of good corporate governance in the UK Corporate Governance Code and related guidance